Global Custom Market Research Reports Provider Company

phone

Global Clinical Nutrition Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

  • Published Date: 08 Nov 2017
  • Number of Pages: 201
  • Category: Healthcare and Medical
  • Country: Global
Global Clinical Nutrition Market:

Global clinical nutrition market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for clinical nutrition products is projected to reach US$ XX Mn by 2023.

Clinical nutrition is the basic knowledge of treatment and diagnosis of disease which affects the intestinal absorption, metabolism and intake of constituents of diet, and to t promotion of health by preventing diet-related diseases. Clinical nutrition products are a kind of pharmaceutical products which help in keeping the patient healthy. Clinical nutrition products also helps in improving the metabolic system of body by providing optimal amounts of supplements like vitamins, minerals etc. Clinical nutrition products improve digestion, absorption, and metabolism, storage of nutrients, transportation, and discharge of waste from the human body.

The global market for clinical nutrition is propelling owing to the growing geriatric population who are highly prone to the major health issues related to the metabolic disorders & loss of appetite. Increase in initiatives taken by the governments, Malnutrition, rise in junk foods intake, poverty, lack in awareness are the factors that are fuelling the growth of clinical nutrition market growth. However, strict government regulations, low reimbursement policies, volatility of the market, patient compliance complexities are the factors hampering the market growth.

Clinical nutrition Market is segmented on the basis of product type, disease conditions, and route of administration, distribution channel, and region.

On the basis of product type, clinical nutrition market is segmented as:

Vitamins and Minerals
Pre/Probiotic
Amino Acids
Glucose
Lipids
Omega Fatty Acids
Others

On the basis of medical conditions, clinical nutrition market is segmented as:

Metabolic Disorders
Neurological Disorders
Gastrointestinal Disorders
Eating Disorders
Others

On the basis of route of administration, clinical nutrition market is segmented as:

Oral
Enteral
Parenteral
On the basis of distribution channel, clinical nutrition market is segmented as:

Hospital Pharmacies
Retail Pharmacies
Others

The progressive impact of growing population pool of baby boomers is protruded to remain as an intermediate in coming years as expectancy of life is expected to increase due to improvement of standards of health. Rise in the incidence rate of chronic diseases like diabetes, cancer, and HIV/AIDS is driving the global clinical nutrition market growth. In paediatric category, increasing demand for the clinical nutrition is emerged as budding opportunity for market of the clinical nutrition. Growing home care use of nutritional products is anticipated to increase demand for the clinical nutrition market.

Based on geographical region, the global clinical nutrition market is segmented as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia- Pacific is dominating the global market of clinical nutritional products. Owing to the high birth rate in countries like India and China are expected to drive the demand for the clinical nutrition products, especially for infant nutrition products. As per the World Bank Group, India has highest birth-rate in APAC region in 2012. In Europe, France and UK have highest birth rate in same year. North America and the Europe are anticipated to dominate global clinical nutrition products market during the forecast period owing the rising investments from the manufacturers in R&D for the innovation of novel products with enhancement of nutrition.

Some of the players in clinical nutrition market are Ajinomoto Co. Inc., Perrigo Company Plc Abbott Nutrition Inc., Baxter International Inc., Danon Baby and Medical Nutrition BV, B. Braun Medical Inc., Fresenius Kabi AG, Hospira (Pfizer) Inc., Gentiva Health Services Inc., Hero Nutritional Inc., and Nestle SA.

In April 2012, Nestle acquired Pfizer Nutrition to increase its position in infant nutrition market globally

In March 2014,Perrigo Company plc and KanPak LLC entered into partnership for manufacturing adult nutritional drinks

In April 2016, Perrigo Company plc, launched Glucernaaseptic nutritional shake for diabetic people

In July 2017, Perrigo Company plc received U.S. FDA approval of AB rated ANDA referencing DermOticOil Ear Drops

Report Outline:

The report provides granular level information about the market size, regional market share and forecast from 2017-2023
The report covers in-detail insights about the competitors overview, key findings and their key strategies
The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
The report tracks recent innovations, key developments and startups details that are working in the industry
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
Publisher Name : Precision Business Insights
1. Executive summary
2. Global Clinical Nutrition Market Introduction
2.1. Global Clinical Nutrition Market Taxonomy
2.2. Global Clinical Nutrition Market Definitions
2.2.1. Product Type
2.2.2. Application
2.2.3. End-User
3. Global Clinical Nutrition Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Clinical Nutrition Market Dynamics Factors Impact Analysis
3.6. Global Clinical Nutrition Market Regulations
3.6.1. U.S
3.6.2. Europe
3.6.3. Japan
3.7. Global Clinical Nutrition Market Recent Product Innovations
4. Global Clinical Nutrition Market Analysis, 2012 - 2016 and Forecast, 2017 2023
4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. Global Clinical Nutrition Market , By Product Type, 2012 - 2016 and Forecast, 2017 - 2023
5.1. Vitamins and Minerals
5.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Pre/Probiotic
5.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Amino Acids
5.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Glucose
5.4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Lipids
5.5.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Omega Fatty Acids
5.6.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Others
5.7.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
6. Global Clinical Nutrition Market , By Medical Condition, 2012 - 2016 and Forecast, 2017 - 2023
6.1. Metabolic Disorders
6.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Neurological Disorders
6.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Gastrointestinal Disorders
6.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Eating Disorders
6.4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Clinical Nutrition Market Forecast, By Route of administration, 2012 - 2016 and Forecast, 2017 - 2023
7.1. Oral
7.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Enteral
7.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Parenteral
7.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Clinical Nutrition Market Forecast, By Distribution Channel, 2012 - 2016 and Forecast, 2017 - 2023
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Others
8.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Clinical Nutrition Market Forecast, By Region, 2012 - 2016 and Forecast, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 2016 and Forecast, 2017 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, medical condition, route of administration, distribution channel and Region, 2017 2023
10. North America Clinical Nutrition Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
10.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1.1. Vitamins and Minerals
10.1.1.2. Pre/Probiotic
10.1.1.3. Amino Acids
10.1.1.4. Glucose
10.1.1.5. Lipids
10.1.1.6. Omega Fatty Acids
10.1.1.7. Others
10.1.2. Medical condition Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.2.1. Metabolic Disorders
10.1.2.2. Neurological Disorders
10.1.2.3. Gastrointestinal Disorders
10.1.2.4. Eating Disorders
10.1.2.5. Others
10.1.3. Route of Administration Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.1.3.1. Oral
10.1.3.2. Enteral
10.1.3.3. Parenteral
10.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.1.4.1. U.S.
10.1.4.2. Canada
10.1.5. North America Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 2023
10.1.6. North America Clinical Nutrition Market Dynamics Trends
11. Europe Clinical Nutrition Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
11.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1.1. Vitamins and Minerals
11.1.1.2. Pre/Probiotic
11.1.1.3. Amino Acids
11.1.1.4. Glucose
11.1.1.5. Lipids
11.1.1.6. Omega Fatty Acids
11.1.1.7. Others
11.1.2. Medical condition Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.2.1. Metabolic Disorders
11.1.2.2. Neurological Disorders
11.1.2.3. Gastrointestinal Disorders
11.1.2.4. Eating Disorders
11.1.2.5. Others
11.1.3. Route of Administration Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.3.1. Oral
11.1.3.2. Enteral
11.1.3.3. Parenteral
11.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.1.4.1. Germany
11.1.4.2. UK
11.1.4.3. France
11.1.4.4. Spain
11.1.4.5. Italy
11.1.4.6. Russia
11.1.4.7. Poland
11.1.4.8. Rest of Europe
11.1.5. Europe Clinical Nutrition Market - By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 2023
11.1.6. Europe Clinical Nutrition Market Dynamics Trends
12. Asia-Pacific Clinical Nutrition Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
12.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1.1. Vitamins and Minerals
12.1.1.2. Pre/Probiotic
12.1.1.3. Amino Acids
12.1.1.4. Glucose
12.1.1.5. Lipids
12.1.1.6. Omega Fatty Acids
12.1.1.7. Others
12.1.2. Medical condition Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.2.1. Metabolic Disorders
12.1.2.2. Neurological Disorders
12.1.2.3. Gastrointestinal Disorders
12.1.2.4. Eating Disorders
12.1.2.5. Others
12.1.3. Route of Administration Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.1.3.1. Oral
12.1.3.2. Enteral
12.1.3.3. Parenteral
12.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.1.4.1. Japan
12.1.4.2. China
12.1.4.3. India
12.1.4.4. ASEAN
12.1.4.5. Australia & New Zealand
12.1.4.6. Rest of Asia-Pacific
12.1.5. Asia-Pacific Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 2023
12.1.6. Asia-Pacific Clinical Nutrition Market Dynamics Trends
13. Latin America Clinical Nutrition Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
13.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1.1. Vitamins and Minerals
13.1.1.2. Pre/Probiotic
13.1.1.3. Amino Acids
13.1.1.4. Glucose
13.1.1.5. Lipids
13.1.1.6. Omega Fatty Acids
13.1.1.7. Others
13.1.2. Medical condition Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.2.1. Metabolic Disorders
13.1.2.2. Neurological Disorders
13.1.2.3. Gastrointestinal Disorders
13.1.2.4. Eating Disorders
13.1.2.5. Others
13.1.3. Route of Administration Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.3.1. Oral
13.1.3.2. Enteral
13.1.3.3. Parenteral
13.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.1.4.1. Brazil
13.1.4.2. Mexico
13.1.4.3. Argentina
13.1.4.4. Venezuela
13.1.4.5. Rest of Latin America
13.1.5. Latin America Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 2023
13.1.6. Latin America Clinical Nutrition Market Dynamics Trends
14. Middle East and Africa Clinical Nutrition Market Analysis, 2012 - 2016 and Forecast, 2017 - 2023
14.1.1. Product Type Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1.1. Vitamins and Minerals
14.1.1.2. Pre/Probiotic
14.1.1.3. Amino Acids
14.1.1.4. Glucose
14.1.1.5. Lipids
14.1.1.6. Omega Fatty Acids
14.1.1.7. Others
14.1.2. Medical condition Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.2.1. Metabolic Disorders
14.1.2.2. Neurological Disorders
14.1.2.3. Gastrointestinal Disorders
14.1.2.4. Eating Disorders
14.1.2.5. Others
14.1.3. Route of Administration Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.1.3.1. Oral
14.1.3.2. Enteral
14.1.3.3. Parenteral
14.1.4. Country Analysis (2012 2016) and Forecast (2017 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.4.1. Gulf Cooperation Council (GCC) Countries
14.1.4.2. Israel
14.1.4.3. South Africa
14.1.4.4. Rest of MEA
14.1.5. MEA Clinical Nutrition Market - Opportunity Analysis Index, Opportunity Analysis Index, By Product Type, Medical condition, Route of administration, Distribution channel and Country, 2017 2023
14.1.6. MEA Clinical Nutrition Market Dynamics Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Ajinomoto Co. Inc.
15.2.2. Perrigo Company Plc
15.2.3. Abbott Laboratories
15.2.4. Baxter International Inc.
15.2.5. Danon Baby and Medical Nutrition BV
15.2.6. B. Braun Medical Inc.
15.2.7. Fresenius Kabi AG
15.2.8. Hospira (Pfizer) Inc.
15.2.9. Gentiva Health Services Inc.
15.2.10. Hero Nutritional Inc.
15.2.11. Nestle SA.
16. Research Methodology
Key Assumptions and Acronyms


Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The companys lead drug candidate

View Report

AFGlobal Corp (AFGlobal), formerly Ameriforge Group Inc is an engineering company that offers manufacturing, technology and precision engineering services. The companys products include integrated riser systems, integrated subsea systems, crushable

View Report

Global Geophysical Services Inc (Global Geophysical) is an oil and gas company that offers geophysical technology solutions. The company offers consulting; reservoir grade 3D data sets and land and marine

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports